{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,5]],"date-time":"2025-06-05T04:11:26Z","timestamp":1749096686608,"version":"3.41.0"},"reference-count":7,"publisher":"Cambridge University Press (CUP)","issue":"6","license":[{"start":{"date-parts":[[2014,11,7]],"date-time":"2014-11-07T00:00:00Z","timestamp":1415318400000},"content-version":"unspecified","delay-in-days":3446,"URL":"https:\/\/www.cambridge.org\/core\/terms"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["CNS spectr."],"published-print":{"date-parts":[[2005,6]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>A 48-year-old woman suffering from treatment-resistant psychogenic stiff neck and severe depression had been treated with a varied regimen of medications, including antidepressants, neuroleptics, and antiepileptics. These treatments did not result in improvement. Therefore, she was treated with a combination of sertraline and risperidone. Depressive symptoms decreased within a few weeks of treatment initiation. The psychogenic stiff neck, which had begun to improve within the first 2 weeks, had disappeared completely after 6 months of treatment with risperidone alone. This case report suggests that risperidone may be effective in some neurological motor disorders comorbid with mood disorders.<\/jats:p>","DOI":"10.1017\/s1092852900023129","type":"journal-article","created":{"date-parts":[[2016,8,2]],"date-time":"2016-08-02T04:42:30Z","timestamp":1470112950000},"page":"443-444","source":"Crossref","is-referenced-by-count":3,"title":["Effectiveness of Risperidone in Psychogenic Stiff Neck"],"prefix":"10.1017","volume":"10","author":[{"given":"Donatella","family":"Marazziti","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bernardo","family":"Dell'Osso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"56","published-online":{"date-parts":[[2014,11,7]]},"reference":[{"key":"S1092852900023129_ref006","doi-asserted-by":"publisher","DOI":"10.1002\/1531-8257(199903)14:2<377::AID-MDS1034>3.0.CO;2-N"},{"key":"S1092852900023129_ref004","doi-asserted-by":"publisher","DOI":"10.1097\/00004583-200402000-00017"},{"key":"S1092852900023129_ref005","doi-asserted-by":"publisher","DOI":"10.1097\/00004714-199704000-00023"},{"key":"S1092852900023129_ref003","doi-asserted-by":"publisher","DOI":"10.1016\/0361-9230(83)90183-1"},{"key":"S1092852900023129_ref002","doi-asserted-by":"publisher","DOI":"10.1007\/s11940-003-0007-y"},{"key":"S1092852900023129_ref007","doi-asserted-by":"publisher","DOI":"10.1002\/mds.1258"},{"key":"S1092852900023129_ref001","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1176\/jnp.11.2.176","article-title":"Pharmacologic efficacy in neuropsychiatry: a review of placebo-controlled treatment trials. A report of the ANPA Committee on Research","volume":"11","author":"Rummans","year":"1999","journal-title":"J Neuropsychiatry Clin Neurosci"}],"container-title":["CNS Spectrums"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cambridge.org\/core\/services\/aop-cambridge-core\/content\/view\/S1092852900023129","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,4]],"date-time":"2025-06-04T10:57:02Z","timestamp":1749034622000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cambridge.org\/core\/product\/identifier\/S1092852900023129\/type\/journal_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,6]]},"references-count":7,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2005,6]]}},"alternative-id":["S1092852900023129"],"URL":"https:\/\/doi.org\/10.1017\/s1092852900023129","relation":{},"ISSN":["1092-8529","2165-6509"],"issn-type":[{"type":"print","value":"1092-8529"},{"type":"electronic","value":"2165-6509"}],"subject":[],"published":{"date-parts":[[2005,6]]}}}